Fig. 2From: MRI radiomics and nutritional-inflammatory biomarkers: a powerful combination for predicting progression-free survival in cervical cancer patients undergoing concurrent chemoradiotherapyRadiomics flow chart for predicting PFS in patients with cervical cancerBack to article page
